Last reviewed · How we verify
NCT03616327
Workflow Validation of an In-Home Feedback Controlled Mandibular Positioner
NA trial testing MATRx in-lab, MATRx plus in Obstructive Sleep Apnea in 10 participants. Completed in 19 August 2019.
15 August 2019
Quick facts
| Lead sponsor | Zephyr Sleep Technologies |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 10 |
| Start date | 1 November 2017 |
| Primary completion | 15 August 2019 |
| Estimated completion | 19 August 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- MATRx in-lab, MATRx plus
Conditions studied
- Obstructive Sleep Apnea — all drugs for Obstructive Sleep Apnea →
Sponsor
Zephyr Sleep Technologies
Who can join
18 and older, any sex, with Obstructive Sleep Apnea. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the study is to test the workflow of the MATRx and MATRx plus feedback controlled mandibular positioner in its intended setting and considerations related to decision making by the care provider. The workflow includes the participant's recruitment into the study, the screening process, visits at the dentist, home sleep tests, and the decision made regarding oral appliance therapy based on the results of the sleep tests.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03616327
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obstructive Sleep Apnea
Currently open trials in the same condition.
- NCT07195253 — Oro-myofunctional Characteristics and Obstructive Sleep Apnea in Infants With Down Syndrome · recruiting
- NCT07273019 — Tongue Muscular Assessment in Children With Sleep Disordered Breathing · NA · recruiting
- NCT07447011 — Glaucoma Respsosne to Lifestyle Corrections in Sleep Apnea · NA · recruiting
- NCT07397780 — RPMO2 Oximeter Accuracy During Sleep 1 Trial · active not recruiting
- NCT06698809 — Obstructive Sleep Apnea Therapeutic Intervention for REsiDual Sleepiness · NA · recruiting
Other Zephyr Sleep Technologies trials
Trials by the same sponsor.
- NCT03812692 — Validation of a Simplified MATRx Plus · completed
- NCT03579225 — Improving the Efficiency of the Digital Sleep Workflow Using MATRx Plus · completed
- NCT03627169 — PSG Validation of MATRx Plus AHI · completed
- NCT03217383 — Predictive Accuracy of MATRx Plus in Identifying Favorable Candidates for Oral Appliance Therapy · NA · completed
- NCT03049982 — A Study for Obstructive Sleep Apnea Using a New At-Home Sleep Test · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03616327 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zephyr Sleep Technologies
- Last refreshed: 21 August 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03616327.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing